CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells

By                                    

International Journal of Oncology, Vol. 46, Iss. 4, 2015-01 ,pp. : 1560-1572

Spandidos Publications

Access to resources Recommend Favorite

Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer

By Obinata Daisuke   Takayama Kenichi   Takahashi Satoru   Inoue Satoshi  

Cancers, Vol. 9, Iss. 3, 2017-02 ,pp. : 22-22

MDPI

Access to resources Recommend Favorite

Human kallikrein 2 (KLK2) promotes prostate cancer cell growth via function as a modulator to promote the ARA70-enhanced androgen receptor transactivation

By Shang Zhiqun   Niu Yuanjie   Cai Qiliang   Chen Jing   Tian Jing   Yeh Shuyuan   Lai Kuo-Pao   Chang Chawnshang  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 1881-1890

Springer Publishing Company

Access to resources Recommend Favorite

Molecular mechanisms of castration-resistant prostate cancer progression

By Dutt Smitha S   Gao Allen C  

Future Oncology, Vol. 5, Iss. 9, 2009-11 ,pp. : 1403-1413

Future Medicine

Access to resources Recommend Favorite

The role of enzalutamide in the treatment of castration-resistant prostate cancer

By Rawlinson Alex   Mohammed Aza   Miller Marek   Kunkler Roger  

Future Oncology, Vol. 8, Iss. 9, 2012-09 ,pp. : 1073-1081

Future Medicine

Access to resources Recommend Favorite